PD-L1 testing in advance stage lung cancer using cytology samples: suitability and interobserver agreement. How well are we doing?

被引：0
|
作者：
Elshiekh, M. [1 ]
Iles, S. [1 ]
Hopcroft, D. [1 ]
Trivedi, P. [1 ]
Gupta, N. [1 ]
Bhagwat, P. [1 ]
Viola, P. [1 ]
机构：
[1] Imperial Coll NHS Trust, Cellular Dept, Hammersmith Hosp, London, England
来源：
LUNG CANCER | 2019年 / 127卷
关键词：
D O I：
10.1016/S0169-5002(19)30094-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
50
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 38 条
  • [11] PD-L1 Testing On the EBUS-FNA Cytology Specimens of Non-Small Cell Lung Cancer
    Wang, Gang
    Ionescu, Diana
    Lee, Cheng-Han
    Hiruki, Tadaaki
    Lam, Stephen
    Melosky, Barbara
    Zhou, Chen
    LABORATORY INVESTIGATION, 2019, 99
  • [12] Efficiency of PD-L1 Testing on Non-Small Cell Lung Cancer Cytology Specimens: An Institutional Experience
    Kravtsov, Oleksandr
    Sheinin, Yuri
    Hartley, Christopher
    Hunt, Bryan
    Felix, Juan
    Giorgadze, Tamar
    MODERN PATHOLOGY, 2019, 32
  • [13] PD-L1 testing on the EBUS-FNA cytology specimens of non-small cell lung cancer
    Wang, Gang
    Ionescu, Diana N.
    Lee, Cheng-Han
    Hiruki, Tadaaki
    Myers, Renelle
    Shaipanich, Tawimas
    Lam, Stephen
    Melosky, Barbara
    Zhou, Chen
    LUNG CANCER, 2019, 136 : 1 - 5
  • [14] Challenges in PD-L1 Immunoexpression in Liquid Based Cytology Samples of Advanced Stage Non-Small Cell Lung Carcinomas
    Jain, D.
    K, S.
    Mohan, A.
    Iyer, V.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S550 - S551
  • [15] Feasibility Of Pd-L1 Expression Testing In Non-Small Cell Lung Cancer From Ebus-Tbna Samples
    Lee, J. M.
    Kim, J. S.
    Heymann, J. J.
    Pagan, C.
    Crapanzano, J. P.
    Fazlollahi, L.
    Haghighi, M.
    Stoopler, M. B.
    Sonett, J. R.
    Sacher, A. G.
    Shu, C. A.
    Rizvi, N. A.
    Bulman, W. A.
    Saqi, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [16] Feasibility Of Pd-L1 Expression Testing In Non-Small Cell Lung Cancer From Pleural And Pericardial Effusion Samples
    Kim, J. S.
    Heymann, J. J.
    Pagan, C.
    Crapanzano, J. P.
    Fazlollahi, L.
    Haghighi, M.
    Stoopler, M. B.
    Sonett, J. R.
    Sacher, A. G.
    Shu, C. A.
    Rizvi, N. A.
    Bulman, W. A.
    Saqi, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [17] PD-L1 Testing of EBUS-TBNA Samples Acquired for the Diagnosis and Staging of Non-Small Cell Lung Cancer: Feasibility and Results
    Smith, A.
    Wang, H.
    Zerbo, A.
    Beaudoin, S.
    Ofiara, L. M.
    Benedetti, A.
    Gonzalez, A. V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [18] Are endobronchial ultrasound-guided transbronchial needle aspiration samples adequate for PD-L1 testing in non-small cell lung cancer?
    Falconer, W.
    Bhatt, N.
    Medford, A.
    LUNG CANCER, 2019, 127 : S18 - S18
  • [19] Clinical Outcomes of Histology Versus Cytology PD-L1 22C3 Antibody Testing in Advanced Non-Small Cell Lung Cancer
    Wang, Y.
    Butcher, M.
    Naqvi, A.
    Cutz, J.
    Juergens, R.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S764 - S764
  • [20] Updated Analysis of Outcomes by Histology vs Cytology PD-L1 22C3 Antibody Testing in Advanced Non-Small Cell Lung Cancer
    Sathiyapalan, A.
    Wang, Y.
    Juergens, R.
    Butcher, M.
    Naqvi, A.
    Cutz, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S379 - S380
1234